Jim Grant on Bubbles And Bargains: Biotech And Russia

0

Founder and publisher of Jim Grant’s Interest Rate Observer about biotech, Russian stocks and the untitled burrito, in this interview with Steve Forbes.

Full interview embedded below.

Jim Grant on Bubbles And Bargains

Despite 60% Loss On Shorts, Yarra Square Up 20% In 2020

Yarra Square Investing Greenhaven Road CapitalYarra Square Partners returned 19.5% net in 2020, outperforming its benchmark, the S&P 500, which returned 18.4% throughout the year. According to a copy of the firm's fourth-quarter and full-year letter to investors, which ValueWalk has been able to review, 2020 was a year of two halves for the investment manager. Q1 2021 hedge fund Read More


No posts to display